Online Media Kit

FEATURED STORY

July 30, 2020 | Aidsmap (UK)

The vaginal ring against HIV: regulatory approval for a new prevention choice for women

The dapivirine ring is the first HIV prevention option specifically designed for women since the female condom was approved nearly 30 years ago. More »

FEATURED STORY

July 25, 2020 | SABC News (South Africa)

HIV Vaginal Ring

A vaginal ring has moved one step closer to becoming a new HIV prevention method for women in sub-Saharan Africa.  More »

FEATURED STORY

July 24, 2020 | Times LIVE (South Africa)

Vaginal ring gives women more options for HIV prevention

Access to a long-acting vaginal ring, which was tested in SA and showed promising results, is getting closer to reality after Europe’s regulatory body gave it the thumbs-up. More »

FEATURED STORY

February 26, 2016 | The New York Times editorial

Helping Women in Africa Avoid H.I.V.

Now, women in the developing world have new hope. The results of two major studies in Africa that were released Monday show that a new device could help protect women against H.I.V. More »

Media Highlights

July 15, 2020 | Microbicide Trials Network (MTN)

Baby Steps to Giant Strides: MTN’s approach to HIV prevention research with pregnant and breastfeeding women

The increased risk of HIV in these populations is now widely recognized. In 2020, MTN is implementing two studies of the monthly dapivirine vaginal ring and Truvada® as daily PrEP in pregnant and... More »

July 14, 2020 | Daily Trust (Nigeria)

HIV: Nigeria needs national PrEP roadmap to ensure equitable access

The executive director of the New HIV Vaccine and Microbicides Advocacy Society discusses the status of microbicides, oral PrEP, and HIV prevention research. More »

July 08, 2020 | Healio

Researchers highlight importance of youth, women in HIV prevention research

An AIDS 2020 press conference highlighted the importance of involving young people and women, and of alternative HIV prevention methods like the dapivirine ring. More »

July 07, 2020 | AVAC

Injectable PrEP is Highly Effective for Some Populations and Must Move Forward as Quickly as Possible

AVAC welcomes promising HIV prevention results and calls for action to enable access to potential long-acting prevention options like injectable cabotegravir and the dapivirine ring.  More »

July 06, 2020 | FHI 360's Degrees blog

Put a ring on it: Four reasons to make the dapivirine ring an HIV prevention option for women and girls

An analysis of interviews with stakeholders in seven sub-Saharan African countries shows widespread enthusiasm for the ring as part of comprehensive HIV prevention programming. More »

Pages